Prediction and benefits of minimal disease activity in patients with psoriatic arthritis and active skin disease in the ADEPT trial.

Although the differences did not reach statistical significance at any time point, this may indicate that delay in introduction of effective therapy could negatively impact MDA achievement, even in patients with long-standing PsA.

also in 111,027 other papers